LABORATORY CORP OF AMERICA HOLDINGS Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LABORATORY CORP OF AMERICA HOLDINGS for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2015 | LH | LABORATORY CORP OF ... | HERRING JOSEPH L | CEO of Covance Drug ... | Sell | S | 122.03 | 6,158 | 751,448 | 0 | 6.2 K to 0 (-100.00 %) |
| Feb 27 2015 | LH | LABORATORY CORP OF ... | HERRING JOSEPH L | CEO of Covance Drug ... | Sell | S | 121.56 | 30,718 | 3,733,982 | 6,158 | 36.9 K to 6.2 K (-83.30 %) |
| Feb 25 2015 | LH | LABORATORY CORP OF ... | HERRING JOSEPH L | CEO of Covance Drug ... | Option Exercise | A | 0.00 | 19,990 | 0 | 19,990 | |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 547 | 0 | 1,647 | |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 116.84 | 178 | 20,798 | 6,382 | 6.6 K to 6.4 K (-2.71 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 547 | 0 | 6,560 | 6 K to 6.6 K (+9.10 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 8,270 | 0 | 24,957 | |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 116.84 | 3,945 | 460,934 | 65,058 | 69 K to 65.1 K (-5.72 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 8,270 | 0 | 69,003 | 60.7 K to 69 K (+13.62 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Brecher Mark E | Chief Medical Offic ... | Option Exercise | M | 0.00 | 547 | 0 | 1,674 | |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Brecher Mark E | Chief Medical Offic ... | Payment of Exercise | F | 116.84 | 177 | 20,681 | 6,743 | 6.9 K to 6.7 K (-2.56 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Brecher Mark E | Chief Medical Offic ... | Buy | M | 0.00 | 547 | 0 | 6,920 | 6.4 K to 6.9 K (+8.58 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 547 | 0 | 1,814 | |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 116.84 | 178 | 20,798 | 20,099 | 20.3 K to 20.1 K (-0.88 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 547 | 0 | 20,277 | 19.7 K to 20.3 K (+2.77 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,540 | 0 | 17,037 | |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 116.84 | 510 | 59,588 | 2,148 | 2.7 K to 2.1 K (-19.19 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,540 | 0 | 2,658 | 1.1 K to 2.7 K (+137.75 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 3,333 | 0 | 14,285 | |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 2,837 | 0 | 17,618 | |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Sell | S | 116.66 | 1,986 | 231,687 | 25,821 | 27.8 K to 25.8 K (-7.14 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Sell | S | 116.66 | 1,897 | 221,304 | 27,807 | 29.7 K to 27.8 K (-6.39 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Payment of Exercise | F | 116.84 | 1,347 | 157,383 | 29,704 | 31.1 K to 29.7 K (-4.34 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Buy | M | 0.00 | 3,333 | 0 | 31,051 | 27.7 K to 31.1 K (+12.02 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Payment of Exercise | F | 116.84 | 940 | 109,830 | 27,718 | 28.7 K to 27.7 K (-3.28 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Buy | M | 0.00 | 2,837 | 0 | 28,658 | 25.8 K to 28.7 K (+10.99 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Sell | S | 116.71 | 2,714 | 316,751 | 25,821 | 28.5 K to 25.8 K (-9.51 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 550 | 0 | 2,194 | |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 116.73 | 212 | 24,747 | 6,013 | 6.2 K to 6 K (-3.41 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 550 | 0 | 6,225 | 5.7 K to 6.2 K (+9.69 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 4,056 | 0 | 20,455 | |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Payment of Exercise | F | 116.73 | 1,342 | 156,652 | 28,535 | 29.9 K to 28.5 K (-4.49 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP, Chief Operatin ... | Buy | M | 0.00 | 4,056 | 0 | 29,877 | 25.8 K to 29.9 K (+15.71 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | Brecher Mark E | Chief Medical Offic ... | Option Exercise | M | 0.00 | 563 | 0 | 2,221 | |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | Brecher Mark E | Chief Medical Offic ... | Payment of Exercise | F | 116.73 | 213 | 24,863 | 6,373 | 6.6 K to 6.4 K (-3.23 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | Brecher Mark E | Chief Medical Offic ... | Buy | M | 0.00 | 563 | 0 | 6,586 | 6 K to 6.6 K (+9.35 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 633 | 0 | 2,361 | |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 116.73 | 228 | 26,614 | 19,730 | 20 K to 19.7 K (-1.14 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 633 | 0 | 19,958 | 19.3 K to 20 K (+3.28 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,673 | 0 | 18,577 | |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 116.73 | 555 | 64,785 | 1,118 | 1.7 K to 1.1 K (-33.17 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,673 | 0 | 1,673 | 0 to 1.7 K |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 8,343 | 0 | 33,227 | |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 116.73 | 3,262 | 380,773 | 60,733 | 64 K to 60.7 K (-5.10 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 8,343 | 0 | 63,995 | 55.7 K to 64 K (+14.99 %) |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Option Exercise | M | 0.00 | 1,503 | 0 | 172 | |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Buy | M | 0.00 | 1,503 | 0 | 1,503 | 0 to 1.5 K |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | M | 0.00 | 1,503 | 0 | 0 | |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Buy | M | 0.00 | 1,503 | 0 | 3,671 | 2.2 K to 3.7 K (+69.33 %) |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | M | 0.00 | 1,503 | 0 | 0 | |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Buy | M | 0.00 | 1,503 | 0 | 2,127 | 624 to 2.1 K (+240.87 %) |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 0.00 | 1,503 | 0 | 0 | |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Payment of Exercise | F | 115.39 | 151 | 17,424 | 29,426 | 29.6 K to 29.4 K (-0.51 %) |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 0.00 | 1,503 | 0 | 29,577 | 28.1 K to 29.6 K (+5.35 %) |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 0.00 | 1,503 | 0 | 0 | |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 0.00 | 1,503 | 0 | 11,739 | 10.2 K to 11.7 K (+14.68 %) |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,503 | 0 | 0 | |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,503 | 0 | 10,111 | 8.6 K to 10.1 K (+17.46 %) |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | M | 0.00 | 1,503 | 0 | 0 | |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Buy | M | 0.00 | 1,503 | 0 | 3,237 | 1.7 K to 3.2 K (+86.68 %) |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,503 | 0 | 0 | |
| Feb 12 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,503 | 0 | 7,408 | 5.9 K to 7.4 K (+25.45 %) |